Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

venetoclax 10 Cyclophosphamide 6 Azacitidine 5 fludarabine phosphate 4 fludarabine 4 Cytarabine 4 Mycophenolic Acid 3 Mesna 3 Melphalan 3 Bone Marrow Transplantation 3 ruxolitinib 2 revumenib 2 quizartinib 2 ponatinib 2 pembrolizumab 2 Whole-Body Irradiation 2 Rituximab 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Decitabine 2 Daunorubicin 2 Busulfan 2 pirtobrutinib 1 pegaspargase 1 obinutuzumab 1 nelarabine 1 ibrutinib 1 cedazuridine 1 capivasertib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡